Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Psidium guajava Leaf Extracts and Their Quercetin Protect HepG2 Cell Lines Against CCL4 Induced Cytotoxicity.

Vijayakumar K, Rengarajan RL, Radhakrishnan R, Mathew S, Qadri I, Vijaya Anand A.

Indian J Clin Biochem. 2019 Jul;34(3):324-329. doi: 10.1007/s12291-018-0752-z. Epub 2018 Apr 11.

PMID:
31391723
2.

Molecular docking analysis of netropsin and novobiocin with the viral protein targets HABD, MTD and RCD.

Alwabli AS, Alattas SG, Alhebshi AM, Zabermawi NM, Alkenani N, Ghmady KA, Qadri I.

Bioinformation. 2019 Mar 30;15(4):233-239. doi: 10.6026/97320630015233. eCollection 2019.

3.

Staphylococcus aureus Infection in a Pediatric ICU: A Hospital Based Prospective Observational Study.

Qadri I, Malik I, Ahmed K.

Indian J Crit Care Med. 2019 May;23(5):210-212. doi: 10.5005/jp-journals-10071-23162.

4.

Expression profile of MicroRNA: An Emerging Hallmark of Cancer.

Zaheer U, Faheem M, Qadri I, Begum N, Yassine HM, Al Thani AA, Mathew S.

Curr Pharm Des. 2019;25(6):642-653. doi: 10.2174/1386207322666190325122821.

PMID:
30914015
5.

Prevalence of Epstein–Barr Virus Genotypes in Pakistani Lymphoma Patients

Salahuddin S, Khan J, Azhar J, B. Whitehurst C, Qadri I, Shackelford J, Pagano JS, Muhammad D, Richards KL.

Asian Pac J Cancer Prev. 2018 Nov 29;19(11):3153-3159.

6.

The Dual Specificity Role of Transcription Factor FOXO in Type 2-diabetes and Cancer.

Fatima K, Mathew S, Faheem M, Mehmood T, Yassine HM, Al Thani AA, Abdel-Hafiz H, Al Ghamdy K, Qadri I.

Curr Pharm Des. 2018;24(24):2839-2848. doi: 10.2174/1381612824666180911114210.

PMID:
30205794
7.

Consequence of HIV and HCV co-infection on host immune response, persistence and current treatment options.

Sohrab SS, Suhail M, Ali A, Qadri I, Harakeh S, Azhar EI.

Virusdisease. 2018 Mar;29(1):19-26. doi: 10.1007/s13337-018-0424-x. Epub 2018 Jan 27. Review.

8.

Association of HCV mutated proteins and host SNPs in the development of hepatocellular carcinoma.

Suhail M, Sohrab SS, Qureshi A, Tarique M, Abdel-Hafiz H, Al-Ghamdi K, Qadri I.

Infect Genet Evol. 2018 Jun;60:160-172. doi: 10.1016/j.meegid.2018.02.034. Epub 2018 Mar 1. Review.

PMID:
29501636
9.

Hepatitis C Virus-Associated Extrahepatic Manifestations in Lung and Heart and Antiviral Therapy-Related Cardiopulmonary Toxicity.

Ilyas SZ, Tabassum R, Hamed H, Rehman SU, Qadri I.

Viral Immunol. 2017 Nov;30(9):633-641. doi: 10.1089/vim.2017.0009. Epub 2017 Sep 27. Review.

PMID:
28953449
10.

Acute interstitial nephritis and DRESS syndrome without eosinophilia associated with cefepime.

Qadri I, Zeng X, Guo R, Koratala A.

BMJ Case Rep. 2017 Aug 3;2017. pii: bcr-2017-221401. doi: 10.1136/bcr-2017-221401. No abstract available.

11.

Renal keratinising desquamative squamous metaplasia: all that hurts is not stone.

Koratala A, Qadri I, Bird V, Ruchi R.

BMJ Case Rep. 2017 Jul 6;2017. pii: bcr-2017-220682. doi: 10.1136/bcr-2017-220682. No abstract available.

12.

Acoustic and hybrid 3D-printed electrochemical biosensors for the real-time immunodetection of liver cancer cells (HepG2).

Damiati S, Küpcü S, Peacock M, Eilenberger C, Zamzami M, Qadri I, Choudhry H, Sleytr UB, Schuster B.

Biosens Bioelectron. 2017 Aug 15;94:500-506. doi: 10.1016/j.bios.2017.03.045. Epub 2017 Mar 21.

PMID:
28343102
13.

HTLV-1 Associated Neurological Disorders.

Khan MY, Khan IN, Farman M, Al Karim S, Qadri I, Kamal MA, Al Ghamdi K, Harakeh S.

Curr Top Med Chem. 2017;17(12):1320-1330. doi: 10.2174/1568026616666161222141318. Review.

PMID:
28017149
14.

Subscapular abscess associated with buttonhole cannulation technique of arteriovenous fistula for hemodialysis access.

Koratala A, Alquadan KF, Chornyy V, Qadri I, Ejaz AA.

J Vasc Access. 2017 Mar 21;18(2):e18-e19. doi: 10.5301/jva.5000605. No abstract available.

PMID:
27768208
15.

Role of Some Predominant Host Immunomodulators' Single Nucleotide Polymorphisms in Severity of Hepatitis B Virus and Hepatitis C Virus Infection.

Rehman SU, Rauf M, Abbas Z, Hamed MH, Qadri I.

Viral Immunol. 2016 Dec;29(10):536-545. Epub 2016 Sep 27. Review.

PMID:
27676210
16.

Nanomaterial Induced Immune Responses and Cytotoxicity.

Ali A, Suhail M, Mathew S, Shah MA, Harakeh SM, Ahmad S, Kazmi Z, Alhamdan MA, Chaudhary A, Damanhouri GA, Qadri I.

J Nanosci Nanotechnol. 2016 Jan;16(1):40-57. Review.

PMID:
27398432
17.

PCR-Based Molecular Diagnosis of Hepatitis Virus (HBV and HDV) in HCV Infected Patients and Their Biochemical Study.

Riaz MN, Faheem M, Anwar MA, Raheel U, Badshah Y, Akhtar H, Tamanna K, Tahir M, Sadaf Zaidi NU, Qadri I.

J Pathog. 2016;2016:3219793. doi: 10.1155/2016/3219793. Epub 2016 Jun 6.

18.

Hepatitis C virus and neurological damage.

Mathew S, Faheem M, Ibrahim SM, Iqbal W, Rauff B, Fatima K, Qadri I.

World J Hepatol. 2016 Apr 28;8(12):545-56. doi: 10.4254/wjh.v8.i12.545. Review.

19.

Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinoma.

Mathew S, Abdel-Hafiz H, Raza A, Fatima K, Qadri I.

World J Hepatol. 2016 Apr 8;8(10):485-98. doi: 10.4254/wjh.v8.i10.485. Review.

20.

Design, synthesis, structure information and biochemical activity of new floro substituted organotin(IV) carboxylates.

Shah FA, Fatima K, Sabir S, Ali S, Qadri I, ud Din N.

J Photochem Photobiol B. 2016 Jan;154:99-107. doi: 10.1016/j.jphotobiol.2015.10.011. Epub 2015 Oct 17.

PMID:
26708070
21.

Design, synthesis, and delivery studies of organotin(IV) based HCV inhibitor.

Shah FA, Fatima K, Ali S, Qadri I.

Infect Disord Drug Targets. 2015;15(3):153-62.

PMID:
26333781
22.

DNA Mediated Vaccines Delivery Through Nanoparticles.

Shah MA, Ali Z, Ahmad R, Qadri I, Fatima K, He N.

J Nanosci Nanotechnol. 2015 Jan;15(1):41-53. Review.

PMID:
26328304
23.

Upregulated hepatic expression of mitochondrial PEPCK triggers initial gluconeogenic reactions in the HCV-3 patients.

Sheikh TI, Adam T, Qadri I.

Asian Pac J Trop Med. 2015 Aug;8(8):618-23. doi: 10.1016/j.apjtm.2015.07.016. Epub 2015 Jul 29.

24.

In silico inhibition of GABARAP activity using antiepileptic medicinal derived compounds.

Mathew S, Faheem M, Al-Malki AL, Kumosani TA, Qadri I.

Bioinformation. 2015 Apr 30;11(4):189-95. doi: 10.6026/97320630011189. eCollection 2015.

25.

Computational Docking Study of p7 Ion Channel from HCV Genotype 3 and Genotype 4 and Its Interaction with Natural Compounds.

Mathew S, Fatima K, Fatmi MQ, Archunan G, Ilyas M, Begum N, Azhar E, Damanhouri G, Qadri I.

PLoS One. 2015 Jun 1;10(6):e0126510. doi: 10.1371/journal.pone.0126510. eCollection 2015.

26.

Organotin(IV) based anti-HCV drugs: synthesis, characterization and biochemical activity.

Shah FA, Sabir S, Fatima K, Ali S, Qadri I, Rizzoli C.

Dalton Trans. 2015 Jun 14;44(22):10467-78. doi: 10.1039/c5dt00862j.

PMID:
25978123
27.

Comparison of structural architecture of HCV NS3 genotype 1 versus Pakistani genotype 3a.

Fatima K, Azhar E, Mathew S, Damanhouri G, Qadri I.

Biomed Res Int. 2014;2014:749254. doi: 10.1155/2014/749254. Epub 2014 Oct 21.

28.

Unraveling the complex relationship triad between lipids, obesity, and inflammation.

Khan SA, Ali A, Khan SA, Zahran SA, Damanhouri G, Azhar E, Qadri I.

Mediators Inflamm. 2014;2014:502749. doi: 10.1155/2014/502749. Epub 2014 Aug 28. Review.

29.

Potential mechanisms of hepatitis B virus induced liver injury.

Suhail M, Abdel-Hafiz H, Ali A, Fatima K, Damanhouri GA, Azhar E, Chaudhary AG, Qadri I.

World J Gastroenterol. 2014 Sep 21;20(35):12462-72. doi: 10.3748/wjg.v20.i35.12462. Review.

30.

Docking studies of Pakistani HCV NS3 helicase: a possible antiviral drug target.

Fatima K, Mathew S, Suhail M, Ali A, Damanhouri G, Azhar E, Qadri I.

PLoS One. 2014 Sep 4;9(9):e106339. doi: 10.1371/journal.pone.0106339. eCollection 2014.

31.

Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma.

Ali A, Abdel-Hafiz H, Suhail M, Al-Mars A, Zakaria MK, Fatima K, Ahmad S, Azhar E, Chaudhary A, Qadri I.

World J Gastroenterol. 2014 Aug 14;20(30):10238-48. doi: 10.3748/wjg.v20.i30.10238. Review.

32.

Prevalence and genotyping of high risk human papillomavirus in cervical cancer samples from Punjab, Pakistan.

Siddiqa A, Zainab M, Qadri I, Bhatti MF, Parish JL.

Viruses. 2014 Jul 17;6(7):2762-77. doi: 10.3390/v6072762.

33.

In silico studies of medicinal compounds against hepatitis C capsid protein from north India.

Mathew S, Faheem M, Archunan G, Ilyas M, Begum N, Jahangir S, Qadri I, Qahtani MA, Mathew S.

Bioinform Biol Insights. 2014 Jun 23;8:159-68. doi: 10.4137/BBI.S15211. eCollection 2014.

34.

Biomarkers for virus-induced hepatocellular carcinoma (HCC).

Mathew S, Ali A, Abdel-Hafiz H, Fatima K, Suhail M, Archunan G, Begum N, Jahangir S, Ilyas M, Chaudhary AG, Al Qahtani M, Mohamad Bazarah S, Qadri I.

Infect Genet Evol. 2014 Aug;26:327-39. doi: 10.1016/j.meegid.2014.06.014. Epub 2014 Jun 21. Review.

PMID:
24956436
35.

Epigallocatechin-3-gallate inhibits tax-dependent activation of nuclear factor kappa B and of matrix metalloproteinase 9 in human T-cell lymphotropic virus-1 positive leukemia cells.

Harakeh S, Diab-Assaf M, Azar R, Hassan HM, Tayeb S, Abou-El-Ardat K, Damanhouri GA, Qadri I, Abuzenadah A, Chaudhary A, Kumosani T, Niedzwiecki A, Rath M, Yacoub H, Azhar E, Barbour E.

Asian Pac J Cancer Prev. 2014;15(3):1219-25.

36.

Battle against poliovirus in Pakistan.

Fatima K, Qadri I.

J Infect Dev Ctries. 2013 Nov 15;7(11):897-9. doi: 10.3855/jidc.3647.

37.

Over expression of a synthetic gene encoding interferon lambda using relative synonymous codon usage bias in Escherichia coli.

Akhtar H, Akhtar S, Jan SU, Khan A, Zaidi Nu, Qadri I.

Pak J Pharm Sci. 2013 Nov;26(6):1181-8.

PMID:
24191324
38.

Oxidative stress and hepatitis C virus.

Paracha UZ, Fatima K, Alqahtani M, Chaudhary A, Abuzenadah A, Damanhouri G, Qadri I.

Virol J. 2013 Aug 7;10:251. doi: 10.1186/1743-422X-10-251. Review.

39.

Additional glycosylation within a specific hypervariable region of subtype 3a of hepatitis C virus protects against virus neutralization.

Anjum S, Wahid A, Afzal MS, Albecka A, Alsaleh K, Ahmad T, Baumert TF, Wychowski C, Qadri I, Penin F, Dubuisson J.

J Infect Dis. 2013 Dec 1;208(11):1888-97. doi: 10.1093/infdis/jit376. Epub 2013 Aug 1.

PMID:
23908491
40.

Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance.

Qashqari H, Al-Mars A, Chaudhary A, Abuzenadah A, Damanhouri G, Alqahtani M, Mahmoud M, El Sayed Zaki M, Fatima K, Qadri I.

Infect Genet Evol. 2013 Oct;19:113-9. doi: 10.1016/j.meegid.2013.06.025. Epub 2013 Jul 5. Review.

PMID:
23831932
41.

Mutations in the STAT1‑interacting domain of the hepatitis C virus core protein modulate the response to antiviral therapy.

Anjum S, Afzal MS, Ahmad T, Aslam B, Waheed Y, Shafi T, Qadri I.

Mol Med Rep. 2013 Aug;8(2):487-92. doi: 10.3892/mmr.2013.1541. Epub 2013 Jun 25.

PMID:
23799612
42.

Characterization of a virulent bacteriophage LK1 specific for Citrobacter freundii isolated from sewage water.

Chaudhry WN, Haq IU, Andleeb S, Qadri I.

J Basic Microbiol. 2014 Jun;54(6):531-41. doi: 10.1002/jobm.201200710. Epub 2013 May 20.

PMID:
23686910
43.

Prevalence of human immunodeficiency virus infection among transgender men in Rawalpindi (Pakistan).

Akhtar H, Badshah Y, Akhtar S, Kanwal N, Akhtar MN, Zaidi NU, Qadri I.

Virol J. 2012 Oct 8;9:229. doi: 10.1186/1743-422X-9-229.

44.

Increased phosphoenolpyruvate carboxykinase gene expression and steatosis during hepatitis C virus subgenome replication: role of nonstructural component 5A and CCAAT/enhancer-binding protein β.

Qadri I, Choudhury M, Rahman SM, Knotts TA, Janssen RC, Schaack J, Iwahashi M, Puljak L, Simon FR, Kilic G, Fitz JG, Friedman JE.

J Biol Chem. 2012 Oct 26;287(44):37340-51. doi: 10.1074/jbc.M112.384743. Epub 2012 Sep 6.

45.

Bacteriophages and their implications on future biotechnology: a review.

Haq IU, Chaudhry WN, Akhtar MN, Andleeb S, Qadri I.

Virol J. 2012 Jan 10;9:9. doi: 10.1186/1743-422X-9-9. Review.

46.

Post-transcriptional silencing of Notch2 mRNA in chronic lymphocytic [corrected] leukemic cells of B-CLL patients.

Fatima K, Paracha RZ, Qadri I.

Mol Biol Rep. 2012 May;39(5):5059-67. doi: 10.1007/s11033-011-1301-5. Epub 2011 Dec 10. Erratum in: Mol Biol Rep. 2012 Jul;39(7):7839.

PMID:
22161246
47.

An overview: in vitro models of HCV replication in different cell cultures.

Tariq H, Manzoor S, Parvaiz F, Javed F, Fatima K, Qadri I.

Infect Genet Evol. 2012 Jan;12(1):13-20. doi: 10.1016/j.meegid.2011.10.009. Epub 2011 Oct 31. Review.

PMID:
22061839
48.

Hepatitis C virus infection: molecular pathways to insulin resistance.

Parvaiz F, Manzoor S, Tariq H, Javed F, Fatima K, Qadri I.

Virol J. 2011 Oct 18;8:474. doi: 10.1186/1743-422X-8-474. Review.

49.

Phylogenetic and structural analysis of HCV nonstructural protein 4A from Pakistani patients.

Zaidi Nu, Kanwal N, Ghazal A, Fatima K, Javed F, Qadri I.

Virus Genes. 2012 Feb;44(1):1-7. doi: 10.1007/s11262-011-0672-y. Epub 2011 Sep 24.

PMID:
21948004
50.

Isolation and partial characterization of a virulent bacteriophage IHQ1 specific for Aeromonas punctata from stream water.

Ul Haq I, Chaudhry WN, Andleeb S, Qadri I.

Microb Ecol. 2012 May;63(4):954-63. doi: 10.1007/s00248-011-9944-2. Epub 2011 Sep 27.

PMID:
21947462

Supplemental Content

Support Center